Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Slides:



Advertisements
Similar presentations
Peter K. Smith, MD, Robert M. Califf, MD, Robert H
Advertisements

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.
Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,
Manuel Caceres, MD, Darryl S. Weiman, MD, JD 
Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.
Coronary Computed Tomography Angiography for Selecting Coronary Artery Bypass Graft Surgery Candidates  Soo-Yeon Kim, MD, Hye-Jeong Lee, MD, PhD, Young.
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome  Michael J. Mack, MD, Adrian P. Banning,
Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations  Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,
Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery  Itzhak Herz, MD, Yaron Moshkovitz, MD,
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy  Takayuki Ohno, MD, Shinichi.
Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies  Ho Young Hwang, MD, Jin Hyun Kim, MD, Whal Lee,
Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery  Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,
Coronary Artery Revascularization (CARE) Registry: An Observational Study of On- Pump and Off-Pump Coronary Artery Revascularization  George Palmer, MD,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Peter K. Smith, MD  The Annals of Thoracic Surgery 
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease?  Jae-Sung Choi, MD, PhD,
Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?  Serenella Castelvecchio,
Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H
Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery: Development of a Predictive Risk Algorithm  Mitchell J. Magee, MD, Morley A. Herbert,
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies  J. James Edelman,
Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.
Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients  Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.
Long-Term Mortality of Coronary Artery Bypass Graft Surgery and Stenting With Drug- Eluting Stents  Chuntao Wu, MD, PhD, Fabian T. Camacho, MS, Songyang.
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Coronary Revascularization in Patients With Liver Cirrhosis
Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population  Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E
Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis  Suvitesh.
Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis  Michael E. Halkos, MD, S. Tanveer.
Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD 
Improved Outcomes of Total Arterial Myocardial Revascularization in Elderly Patients at Long-Term Follow-Up: A Propensity-Matched Analysis  Gianluigi.
Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease  Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,
Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E
Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L
Predictors for Early and Late Outcomes After Coronary Artery Bypass Grafting in Hemodialysis Patients  Yoshiyuki Takami, MD, Kazuyoshi Tajima, MD, Wataru.
Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?
Peter K. Smith, MD, Robert M. Califf, MD, Robert H
First-year outcomes of beating heart coronary artery bypass grafting using proximal mechanical connectors  Todd M. Dewey, MD, Katherine Crumrine, Morley.
Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus  Yanai Ben-Gal, MD, Yaron Moshkovitz, MD, Nachum Nesher,
Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting  Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting
Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery  Karl F. Welke, MD, Mitchell J. Barnett, PharmD,
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?
On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes  John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan 
Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Sequential In Situ Left Internal Thoracic Artery Grafting to the Circumflex and Right Coronary Artery Areas  Cihat Bakay, MD, Burak Onan, MD, Aşkin Ali.
Lung Transplantation and Coronary Artery Disease
Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis  Timothy S. Lancaster,
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
William T. Brinkman, MD, Morley A. Herbert, PhD, Syma L
Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease  Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa,
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery  Chuntao Wu, MD, PhD, Edward L. Hannan,
Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups  William T. Brinkman, MD, William Hoffman, MD, Todd.
The Impact of New Technology on Cardiothoracic Surgical Practice
Influence of On-Pump Versus Off-Pump Techniques and Completeness of Revascularization on Long-Term Survival After Coronary Artery Bypass  Omar M. Lattouf,
Location of the Second Internal Mammary Artery Graft Does Not Influence Outcome of Coronary Artery Bypass Grafting  Paul A. Kurlansky, MD, Ernest A. Traad,
Previous Percutaneous Coronary Interventions Increase Mortality and Morbidity After Coronary Surgery  Vito Mannacio, MD, Luigi Di Tommaso, MD, Vincenzo.
Kim I. de la Cruz, MD, Faisal G
Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J
Presentation transcript:

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma Prince, RN, Michael J. Mack, MD  The Annals of Thoracic Surgery  Volume 99, Issue 4, Pages 1298-1305 (April 2015) DOI: 10.1016/j.athoracsur.2014.11.035 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Time to first major adverse cardiac event (MACE) event in percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) patients; unmatched patients. The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Time to first major adverse cardiac event (MACE) event in percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) patients; matched patients. The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Time to first major adverse cardiac event (MACE) event in matched groups of drug eluting stents (DES) only and coronary artery bypass grafting (CABG). The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Time to first major adverse cardiac event (MACE) event in insulin-dependent diabetics; percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Time to first major cardiac adverse event (MACE) in non-insulin dependent diabetics; percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions